FDA: Montelukast Tablet Bottles Recalled

Share this content:
FDA: Montelukast Tablet Bottles Recalled
FDA: Montelukast Tablet Bottles Recalled

TUESDAY, Sept. 4, 2018 (HealthDay News) -- Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.

Bottles labeled as containing 30 tablets of 10-milligram montelukast sodium tablets instead contain 90 tablets of losartan potassium tablets.

There is a safety risk because taking losartan when not prescribed can cause renal dysfunction, elevated potassium levels, and low blood pressure. The risk can be especially high for pregnant woman because losartan could harm or kill the fetus, the FDA said Friday.

The recalled bottles have the following lot numbers: MON17384, expiration date: 12/31/2019, and NDC: 31722-726-30. Patients who have the recalled bottles should contact their health care provider or pharmacist immediately, the FDA said.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Warns About 'Miracle' Young Blood Infusion Treatments

FDA Warns About 'Miracle' Young Blood Infusion Treatments

Expensive 'fountain of youth' therapies are unproven, potentially harmful

CDC: Salmonella Cases Tied to Raw Turkey Products Now at 279

CDC: <i>Salmonella</i> Cases Tied to Raw Turkey Products ...

Cases reported in 41 states and the District of Columbia; 107 people have been hospitalized

Chronic Wasting Disease Found in Deer in 24 States

Chronic Wasting Disease Found in Deer in 24 ...

No evidence disease can spread to humans, but hunters should be careful around potentially infected animals

is free, fast, and customized just for you!




Already a member?

Sign In Now »